India’s Sun Pharma names Kirti Ganorkar as managing director
Sun Pharmaceutical , India’s largest drugmaker by revenue, on Friday named Kirti Ganorkar as managing director, effective September 1.
Related Articles
Advanced Imaging for Focal Therapy in Intermediate Risk Prostate Cancer – Matthew Cooperberg
Zachary Klaassen speaks with Matthew Cooperberg about the integration of OnQ™ Prostate assisted Focal One® Robotic HIFU for prostate cancer treatment. Dr. Cooperberg discusses how…
Taking lessons from Ukraine, Taiwan eyes sea drones to counter China
Just off the small Taiwan fishing port of Wushi on its Pacific coast, a Taiwanese company is testing what could eventually be a powerful but…
The Art of the Pivot | Hopkins Bloomberg Public Health Magazine
Pandemics. Wars. Existential financial threats. The Bloomberg School has long used its hard-won experience to anticipate and shape the future.
Interaction molecular QTL mapping discovers cellular and environmental modifiers of genetic regulatory effects
To identify regulatory variants with plasticity in effect size, we performed interaction molecular quantitative trait loci (iQTL) mapping with cell-type abundance, age, sex, and smoking…
India’s Sun Pharma names Kirti Ganorkar as managing director
Sun Pharmaceutical , India’s largest drugmaker by revenue, on Friday named Kirti Ganorkar as managing director, effective September 1.
Novo Nordisk regains crown as Europe’s most valuable company
Drugmaker Novo Nordisk is once again Europe’s largest company by market capitalisation, rising above German software firm SAP on Friday.
Up and down the ladder: The latest comings and goings
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
Real-World Evidence Informs Clinical Decision-Making in Metastatic Castration-Resistant Prostate Cancer – Alan Bryce
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Alan…
Up and down the ladder: The latest comings and goings
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
Combining Alpha and Beta Emitters in PSMA-Targeted Prostate Cancer Therapy – Scott Tagawa
Pedro Barata interviews Scott Tagawa about radioligand therapy research, focusing on actinium-225 PSMA antibody constructs. Dr. Tagawa explains that antibodies like rosopatamab offer advantages over…